Topotecan Supplier-Buyer Network — Trade Flow Analysis

Name: Topotecan Supplier-Buyer Trade Network Dataset — 45+ Indian Exporters, 14+ Importers, 51+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Topotecan supplier network, Topotecan buyers, pharmaceutical export India, Topotecan trade data

TransData Nexus

Topotecan

India Pharmaceutical Trade Intelligence

$3.8M45 Suppliers51 CountriesHS 30049049

ExportsIndia → POLAND29.8%India → NETHERLANDS15.7%

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: ACCORD HEALTHCARE

Who Supplies Topotecan? Top Manufacturers & Buyers 2026 — INTAS PHARMACEUTICALS LIMITED Leads | TransData Nexus | TransData Nexus

1INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the first-largest Topotecan exporter from India, with a market share of 30.8% and a total export value of $1.2M across 414 shipments. Their average shipment value of $2.8K is below the market average of $6.7K, reflecting a high-volume, competitive pricing strategy.

INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• ACCORD HEALTHCARE POLSKA SP Z O O — $257.0K across 92 shipments (22.2% of this supplier's total exports)

• ACCORD FARMACUTICA LTDA. — $257.0K across 92 shipments (22.2% of this supplier's total exports)

• TO THE ORDER — $254.6K across 91 shipments (22.0% of this supplier's total exports)

• ACCORD HEALTHCARE POLSKA SP Z O O — $238.4K across 85 shipments (20.6% of this supplier's total exports)

• ALLOGA FRANCE — $148.6K across 53 shipments (12.9% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (414 shipments) at a per-shipment value of $2.8K, indicating a broad distribution network with many smaller, regular orders.

2VENUS REMEDIES LIMITED

VENUS REMEDIES LIMITED is the second-largest Topotecan exporter from India, with a market share of 3.3% and a total export value of $122.5K across 30 shipments. Their average shipment value of $4.1K is below the market average of $6.7K, reflecting a high-volume, competitive pricing strategy.

VENUS REMEDIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• E P H K — $59.2K across 15 shipments (48.3% of this supplier's total exports)

• VENUS PHARMA GMBH — $23.3K across 6 shipments (19.1% of this supplier's total exports)

• L.B.S.A — $16.5K across 4 shipments (13.5% of this supplier's total exports)

• LABORATORIO BIOSANO — $12.7K across 3 shipments (10.4% of this supplier's total exports)

• H H B S — $10.7K across 3 shipments (8.7% of this supplier's total exports)

Key Insight: VENUS REMEDIES LIMITED operates with high shipment frequency (30 shipments) at a per-shipment value of $4.1K, indicating a broad distribution network with many smaller, regular orders.

3SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the third-largest Topotecan exporter from India, with a market share of 3.0% and a total export value of $111.1K across 4 shipments. Their average shipment value of $27.8K is above the market average of $6.7K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 3 named buyers in our database. M/S. SUN PHARMACEUTICALS MOROCCO LL is the dominant customer, accounting for 56.2% of this supplier's tracked business. Top customers include:

• M/S. SUN PHARMACEUTICALS MOROCCO LL — $62.4K across 2 shipments (56.2% of this supplier's total exports)

• M/S. SUN PHARMACEUTICALS MOROCCO LL — $37.4K across 1 shipments (33.7% of this supplier's total exports)

• M/S.SUN PHARMACEUTIC — $11.2K across 0 shipments (10.1% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $27.8K is 313% above the market average of $6.7K, consistent with large-order contracts or value-added formulations.

4R.S. SURGIPHARM PRIVATE LIMITED

R.S. SURGIPHARM PRIVATE LIMITED is the fourth-largest Topotecan exporter from India, with a market share of 0.4% and a total export value of $13.7K across 7 shipments. Their average shipment value of $2.0K is below the market average of $6.7K, reflecting a high-volume, competitive pricing strategy.

R.S. SURGIPHARM PRIVATE LIMITED serves 1 named buyer in our database. CENTRAL HOSPITAL82 A is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• CENTRAL HOSPITAL82 A — $13.7K across 7 shipments (100.0% of this supplier's total exports)

Key Insight: R.S. SURGIPHARM PRIVATE LIMITED operates with high shipment frequency (7 shipments) at a per-shipment value of $2.0K, indicating a broad distribution network with many smaller, regular orders.

5UNITED BIOTECH PRIVATE LIMITED

UNITED BIOTECH PRIVATE LIMITED is the fifth-largest Topotecan exporter from India, with a market share of 0.3% and a total export value of $10.0K across 23 shipments. Their average shipment value of $436 is below the market average of $6.7K, reflecting a high-volume, competitive pricing strategy.

UNITED BIOTECH PRIVATE LIMITED serves 5 named buyers in our database. M/S. NIKHIL PHARMA P is the dominant customer, accounting for 66.0% of this supplier's tracked business. Top customers include:

• M/S. NIKHIL PHARMA P — $6.6K across 15 shipments (66.0% of this supplier's total exports)

• MSNIKHIL PHARMA PRIV — $1.1K across 2 shipments (10.8% of this supplier's total exports)

• M/S. NIKHIL PHARMA P — $794 across 2 shipments (7.9% of this supplier's total exports)

• M/S. NIKHIL PHARMA P — $789 across 2 shipments (7.9% of this supplier's total exports)

• SALAMA PHARMACEUTICA — $750 across 2 shipments (7.5% of this supplier's total exports)

Key Insight: UNITED BIOTECH PRIVATE LIMITED operates with high shipment frequency (23 shipments) at a per-shipment value of $436, indicating a broad distribution network with many smaller, regular orders.

6ASPIRA BIOHEALTH LLP

ASPIRA BIOHEALTH LLP is the fifth-largest Topotecan exporter from India, with a market share of 0.3% and a total export value of $9.9K across 5 shipments. Their average shipment value of $2.0K is below the market average of $6.7K, reflecting a high-volume, competitive pricing strategy.

ASPIRA BIOHEALTH LLP serves 1 named buyer in our database. TO is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• TO — $9.9K across 5 shipments (100.0% of this supplier's total exports)

Key Insight: ASPIRA BIOHEALTH LLP operates with high shipment frequency (5 shipments) at a per-shipment value of $2.0K, indicating a broad distribution network with many smaller, regular orders.

1Poland

Poland ranks as the first-largest destination for Topotecan imports from India, with a total trade value of $1.1M across 50 shipments — representing a 29.8% share of all Topotecan exports. The average shipment value of $22.4K is above the global average of $6.7K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Topotecan importers in Poland: ACCORD HEALTHCARE POLSKA SP. Z O.O. is the largest buyer, accounting for 52.7% ($589.6K) of this market's total imports.

• ACCORD HEALTHCARE POLSKA SP. Z O.O. — $589.6K (52.7% of Poland's total)

• ACCORD HEALTHCARE POLSKA SP. Z.O.O. — $236.9K (21.2% of Poland's total)

• ACCORD HEALTHCARE POLSKA SP. Z O.O — $52.5K (4.7% of Poland's total)

Key Insight: Poland's per-shipment average of $22.4K (232% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Poland is a key market for Topotecan imports from India.

Primary Market

Secondary Market

2Netherlands

Netherlands ranks as the second-largest destination for Topotecan imports from India, with a total trade value of $589.3K across 51 shipments — representing a 15.7% share of all Topotecan exports. The average shipment value of $11.6K is above the global average of $6.7K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.

Named Topotecan importers in Netherlands: ALLOGA FRANCE is the largest buyer, accounting for 37.5% ($220.8K) of this market's total imports.

• ALLOGA FRANCE — $220.8K (37.5% of Netherlands's total)

• BROCACEF NL : HUB — $112.4K (19.1% of Netherlands's total)

• BROCACEF NL:EU HUB — $70.0K (11.9% of Netherlands's total)

Key Insight: Netherlands's per-shipment average of $11.6K (72% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Netherlands is a key market for Topotecan imports from India.

Primary Market

Secondary Market

3United States

United States ranks as the third-largest destination for Topotecan imports from India, with a total trade value of $559.7K across 18 shipments — representing a 14.9% share of all Topotecan exports. The average shipment value of $31.1K is above the global average of $6.7K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Topotecan importers in United States: EVERSANA LIFE SCIENCES SERVICES,LLC is the largest buyer, accounting for 83.1% ($465.3K) of this market's total imports.

• EVERSANA LIFE SCIENCES SERVICES,LLC — $465.3K (83.1% of United States's total)

• EVERSANA LIFE SCIENCES SERVICES LLC — $70.2K (12.5% of United States's total)

Key Insight: United States's per-shipment average of $31.1K (362% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Topotecan imports from India.

Primary Market

Secondary Market

4Brazil

Brazil ranks as the fourth-largest destination for Topotecan imports from India, with a total trade value of $515.8K across 6 shipments — representing a 13.7% share of all Topotecan exports. The average shipment value of $86.0K is above the global average of $6.7K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Topotecan importers in Brazil: ACCORD FARMACUTICA LTDA is the largest buyer, accounting for 49.8% ($257.0K) of this market's total imports.

• ACCORD FARMACUTICA LTDA — $257.0K (49.8% of Brazil's total)

• ACCORD FARMACUTICA LTDA. — $170.1K (33.0% of Brazil's total)

Key Insight: Brazil's per-shipment average of $86.0K (1178% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Brazil is a key market for Topotecan imports from India.

Primary Market

Secondary Market

5Morocco

Morocco ranks as the fifth-largest destination for Topotecan imports from India, with a total trade value of $111.1K across 2 shipments — representing a 3.0% share of all Topotecan exports. The average shipment value of $55.5K is above the global average of $6.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Topotecan importers in Morocco: M/S. SUN PHARMACEUTICALS MOROCCO LL is the largest buyer, accounting for 56.2% ($62.4K) of this market's total imports.

• M/S. SUN PHARMACEUTICALS MOROCCO LL — $62.4K (56.2% of Morocco's total)

Key Insight: Morocco's per-shipment average of $55.5K (725% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Morocco is a key market for Topotecan imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Topotecan.
2.Flow Mapping: 45 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 558 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 51 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

558 Verified Shipments

45 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Topotecan

Topotecan

Who Supplies Topotecan? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Topotecan? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Topotecan Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1INTAS PHARMACEUTICALS LIMITED

2VENUS REMEDIES LIMITED

3SUN PHARMACEUTICAL INDUSTRIES LIMITED

4R.S. SURGIPHARM PRIVATE LIMITED

5UNITED BIOTECH PRIVATE LIMITED

6ASPIRA BIOHEALTH LLP

From Indian Factories to Global Pharmacies — How Topotecan Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Topotecan Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Poland

2Netherlands

3United States

4Brazil

5Morocco

People Also Ask — Topotecan Supplier & Trade Network

Topotecan Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology